Prevention of Chemotherapy-induced Myelosuppression
1 clinical trials · Condition
◉ Watch Prevention of Chemotherapy-induced Myelosuppression
| Record | Firm | Date |
|---|---|---|
| A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer (NCT05622058) | Aileron Therapeutics, Inc. | 2023-01-09 |
Track Prevention of Chemotherapy-induced Myelosuppression automatically
Every clearance here is in the API, with alerts when new ones post.